Microbix Biosystems Announces Q2 Results Webinar
Company Announcements

Microbix Biosystems Announces Q2 Results Webinar

Microbix Biosystms (TSE:MBX) has released an update.

Microbix Biosystems Inc., a Canadian life sciences company, is set to release its Q2 financial results for fiscal 2024 before the markets open on May 15, 2024, followed by a webinar to discuss the outcomes with top executives. The company, known for producing biological products for human health that support the global diagnostics industry, has seen its annualized revenues approach C$ 2.0 million per month. Interested parties can join the webinar through various online platforms or arrange telephone participation.

For further insights into TSE:MBX stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskMicrobix Enhances HPV Testing with New Validation
TipRanks Canadian Auto-Generated NewsdeskMicrobix Unveils Novel HSV Diagnosis Enhancement
TipRanks Canadian Auto-Generated NewsdeskMicrobix Secures Key EU Accreditations for QAPs
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App